Nutritional And Therapeutic Interventions For Diabetes and Metabolic Syndrome pdf

Debasis Bagchi ha conseguito il dottorato di ricerca. in Chimica Medicinale nel 1982. È Professore nel Dipartimento di Scienze Farmacologiche e Farmaceutiche dell'Università di Houston, College of Pharmacy, Houston, TX. Il Dr. Bagchi è anche il Chief Scientific Officer di Cepham Inc., Piscataway, NJ. Il Dr. Bagchi ha ricevuto il Master of American College of Nutrition Award all'inizio di ottobre 2010. Attualmente è Presidente dell'International Society of Nutraceuticals and Functional Foods (ISNFF), Immediate Past President dell'American College of Nutrition, Clearwater, FL e Past Chair della divisione Nutraceuticals and Functional Foods dell'Institute of Food Technologists (IFT), Chicago, IL. Sta prestando servizio come Distinguished Advisor presso il Japanese Institute for Health Food Standards, Tokyo, Giappone. Il Dr. Bagchi è membro della sezione di studio e del comitato di revisione tra pari del National Institutes of Health (NIH), Bethesda, MD. Il Dr. Bagchi ha 303 articoli su riviste peer reviewed, 25 libri e numerosi brevetti. Il Dr. Bagchi è Membro della Society of Toxicology, Membro della New York Academy of Sciences, Fellow della Nutrition Research Academy e Membro del Comitato degli stakeholder TCE della Wright Patterson Air Force Base, OH. Il Dr. Bagchi è Associate Editors del Journal of Functional Foods e del Journal of the American College of Nutrition, e serve anche come membro del comitato editoriale di numerose riviste sottoposte a revisione paritaria, tra cui Antioxidants & Redox Signaling, Cancer Letters, Toxicology Mechanisms and Methods, The Original Internist e altri.

Nutritional And Therapeutic Interventions For Diabetes and Metabolic Syndrome pdf da Debasis Bagchi

Diabetes mellitus affects approximately 20 million people in the US, or nearly 7% of the population. It is expected to increase by 70% within the next 25 years, and numerous epidemiologic studies have demonstrated that type 2 diabetes increases the risk of cardiovascular morbidity and mortality. It is estimated to cost over $92 billion in health care costs and lost productivity. The increased risk is due to the detrimental vascular effects of prolonged exposure to a hyperglycemic, oxidant-rich environment yielding associated cardiovascular risk factors: atherosclerosis, hypertension and clotting abnormalities. Hypertension and dyslipidemia in diabetic patients produces substantial decreases in cardiovascular and microvascular diseases.

Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome provides an overview of the current epidemic, outlines the consequences of this crisis and lays out strategies to forestall and prevent diabetes, obesity and other intricate issues of metabolic syndrome. The contributing experts from around the world give this book relevant and up-to-date global approaches to the critical consequences of metabolic syndrome and make it an important reference for those working with the treatment, evaluation or public health planning for the effects of metabolic syndrome and diabetes.

• Scientific discussion of the epidemiology and pathophysiology of the relationship between diabetes and metabolic syndrome
• Includes coverage of Pre-diabetes conditions plus both Type I and Type II Diabetes
• Presents both prevention and treatment options